Managed Without Drugs (n = 1,346) | Insulin-Managed (n = 1,428 | Oral Sulfonylurea-Managed (n = 1,791) | ||||
---|---|---|---|---|---|---|
Characteristics | N | (%) | N | (%) | N | (%) |
Gender | ||||||
Male | 600 | (44.6) | 697 | (48.8) | 1,003 | (56.0) |
Female | 746 | (55.4) | 731 | (51.2) | 788 | (44.0) |
Mean Age | 52 ± 14.2 | 51 ± 14.1 | 56 ± 12.3 | |||
Race | N | (%) | N | (%) | N | (%) |
White | 747 | (75.5) | 652 | (65.6) | 814 | (68.5) |
Black | 180 | (18.2) | 305 | (30.7) | 300 | (25.2) |
Other | 62 | (6.3) | 37 | (3.7) | 75 | (6.3) |
Missing | 357 | --- | 434 | --- | 602 | --- |
Eligibility | ||||||
Medicaid | 17 | (1.3) | 10 | (0.7) | 7 | (0.4) |
Medicare | 238 | (17.8) | 242 | (17.2) | 420 | (23.7) |
Commercial | 1,079 | (80.9) | 1,159 | (82.1) | 1,345 | (75.9) |
Missing | 12 | --- | 17 | --- | 19 | --- |
Body Mass Index ‡ | ||||||
Underweight | 13 | (1.2) | 13 | (1.1) | 11 | (0.8) |
Normal | 220 | (19.5) | 249 | (21.2) | 201 | (13.9) |
Overweight | 370 | (32.8) | 377 | (32.0) | 441 | (30.4) |
Obese | 525 | (46.5) | 538 | (45.7) | 797 | (55.0) |
Missing | 218 | --- | 251 | --- | 341 | --- |
Comorbidities | ||||||
None | 444 | (33.0) | 27 | (1.9) | 45 | (2.5) |
1–2 | 570 | (42.4) | 628 | (44.0) | 837 | (46.7) |
3–4 | 250 | (18.6) | 446 | (31.2) | 626 | (35.0) |
5 or More | 82 | (6.1) | 327 | (22.9) | 283 | (15.8) |
Avg # of Comorbidities | 1.57 ± 1.62 | 3.12 ± 2.06 | 2.83 ± 1.73 |